2-58160147-ACT-ACTCT
Variant summary
Our verdict is Pathogenic. The variant received 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_018062.4(FANCL):c.1051_1052dupAG(p.Ser351ArgfsTer19) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000685 in 1,460,790 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_018062.4 frameshift
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 14 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_018062.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| FANCL | NM_018062.4 | MANE Select | c.1051_1052dupAG | p.Ser351ArgfsTer19 | frameshift | Exon 13 of 14 | NP_060532.2 | ||
| FANCL | NM_001438889.1 | c.1096_1097dupAG | p.Ser366ArgfsTer16 | frameshift | Exon 14 of 14 | NP_001425818.1 | |||
| FANCL | NM_001410792.1 | c.1111_1112dupAG | p.Ser371ArgfsTer19 | frameshift | Exon 14 of 15 | NP_001397721.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| FANCL | ENST00000233741.9 | TSL:1 MANE Select | c.1051_1052dupAG | p.Ser351ArgfsTer19 | frameshift | Exon 13 of 14 | ENSP00000233741.5 | ||
| FANCL | ENST00000403295.8 | TSL:1 | c.967_968dupAG | p.Ser323ArgfsTer19 | frameshift | Exon 12 of 13 | ENSP00000386097.3 | ||
| FANCL | ENST00000449070.6 | TSL:1 | c.874_875dupAG | p.Ser292ArgfsTer19 | frameshift | Exon 10 of 11 | ENSP00000401280.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000399 AC: 1AN: 250738 AF XY: 0.00000738 show subpopulations
GnomAD4 exome AF: 6.85e-7 AC: 1AN: 1460790Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 726722 show subpopulations
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Fanconi anemia Pathogenic:1
Variant summary: FANCL c.1051_1052dupAG (p.Ser351ArgfsX19) results in a premature termination codon, not anticipated to result in nonsense mediated decay, but predicted to cause a truncation of the encoded protein, disrupting the last 25 amino acids of the FANCL protein. This truncation is expected to remove two conserved, metal ion binding Cys residues that are part of the RING-type Zinc finger domain of the FANCL protein (amino acids 307 - 365; UniProt). This C-terminal domain is necessary for monoubiquitination of FANCD2 (see e.g. PMID 32048394). The variant allele was found at a frequency of 4e-06 in 250738 control chromosomes (gnomAD). To our knowledge, no occurrence of c.1051_1052dupAG in individuals affected with Fanconi Anemia and no experimental evidence demonstrating its impact on protein function have been reported. However, a downstream truncation variant (c.1096_1099dupATTA (p.Thr367AsnfsX13)), has been reported in the literature in a compound heterozygous patient with milder features of Fanconi anemia (FA), and functional studies suggested that this variant results in a partial loss of FANCL activity, indicating a hypomorphic effect for the variant; this study also demonstrated that the variant found on the opposite allele (in trans) in this patient was a functionally null mutation (PMID 19405097). On the other hand, the variant, c.1095_1098dupAATT, was also reported t in several homozygous control individuals in the gnomAD database, suggesting that this variant might not be sufficient to cause FA phenotype in homozygous state. An overlapping truncation variant (c.1048_1051delCAGA (p.Gln350ValfsX18)), was also described in the literature in a heterozygous patient with premature ovary insufficiency (POI), and authors of this study demonstrated that while the wildtype FANCL protein was predominantly localized in the nuclei, the variant FANCL protein was retained in the cytoplasm, in addition, this variant resulted in loss of ubiquitinligase activity and decreased DNA damage repair capacity (PMID 32048394). Based on their findings, authors proposed haploinsufficiency as a potential causative mechanism for the (provisional) POI phenotype. Other functional studies have shown that Cys 357 is essential for FANCL ubiquitin ligase activity (PMID: 19111657, 17938197). These findings demonstrate that this region of FANCL is critically important to protein function and a disruption is likely to cause disease. ClinVar contains an entry for this variant (Variation ID: 1027625). Based on the evidence outlined above, the variant was classified as likely pathogenic.
Fanconi anemia complementation group L Pathogenic:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at